TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Alistair Ring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.